EPO Patents = 2

Forward Citations = 8

Loading Chart...

2 inventors (with patents filed for the assignee):

Scott Kachlany (8 out of 17 patents)

Benjamin Belinka (5 out of 5 patents)

Benjamin A Belinka, Jr (3 out of 14 patents)

8 patents: Sort by Forward Citations

1. 11612636 - Method of treating autoimmune inflammatory crohn's disease (2023-03-28),

2. 10993989 - Treatment and diagnosis of inflammatory disorders and HIV (2021-05-04),

3. 10603354 - Treatment and diagnosis of inflammatory disorders and HIV (2020-03-31),

4. 10226506 - Treatment and diagnosis of inflammatory disorders and HIV (2019-03-12),

5. 9950030 - Treatment and diagnosis of ocular disease (2018-04-24),

6. 9849156 - Treatment and diagnosis of inflammatory disorders and HIV (2017-12-26),

7. 9724384 - Methods to treat inflammation of the lung (2017-08-08),

8. 9352017 - Combination therapy with leukotoxin (2016-05-31),

Company Overview

Actinobac Biomed, Inc. is a biotechnology company focused on developing novel therapies for infectious diseases. Our team of researchers specialize in harnessing the power of actinobacteria to create innovative treatments that address unmet medical needs. With a strong commitment to scientific excellence and patient care, we strive to bring groundbreaking solutions to the market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#1 in Kendall Park, NJ

#1,343 in New Jersey

#35,941 in US

Kendall Park, NJ, United States of America

Actinobac Biomed, Inc.

Forward Citations = 8

2 inventors:

Scott Kachlany (8 out of 17 patents)

Benjamin Belinka (5 out of 5 patents)

Benjamin A Belinka, Jr (3 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Actinobac Biomed, Inc.. Retrieved from https://idiyas.com/company/actinobac-biomed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]